Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about TFEB: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
A protein referenced in 2 knowledge graph relationships. Key connections: promotes lysosomal_biogenesis (mechanism); semaglutide (drug) activates.
No AI portrait yet
| Gene Symbol | TFEB |
| Aliases | Transcription Factor EB |
| Protein Type | Transcription Factor |
| Target Class | Protein |
| Function | TFEB is constitutively expressed in most cell types, with highest expression in tissues with high lysosomal activity including: |
| Mechanism of Action | Prioritized from 1 SciDEX hypotheses, including: The Mitochondrial-Lysosomal Metabolic Coupling Dysfunction |
| Primary Expression | most cell types, with highest expression in tissues with high lysosomal activity including: |
| Druggability | Undruggable (0.23) |
| Molecular Weight | 53 kDa |
| Pathways | mTOR |
| GeneCards | TFEB |
| Human Protein Atlas | TFEB |
| Metabolic decline in neurodegeneration | Brain glucose hypometabolism precedes clinical symptoms by decades; insulin resistance is a risk factor for AD and PD[@brain2023] |
| TFEB as master regulator | TFEB controls lysosome biogenesis, autophagy, and mitochondrial function—processes that decline with age and neurodegeneration[@tfeb2022] |
| Orthogonal mechanisms | GLP-1 agonists work via hormonal signaling (incretin effect); TFEB activators work via nuclear transcription[@tfeb2022a] |
| Associated Diseases | aging, Als, Alzheimer, Alzheimer's disease, Amyotrophic Lateral Sclerosis |
| Known Drugs/Compounds | bortezomib, curcumin, CURCUMIN, digoxin, ELTROMBOPAG, hederagenin |
| Interactions | ABCA1, ACAT1, ACETYL-COA, ACHE, ACOD1, ACOX1 |
| SciDEX Target | View Target Profile |
| SciDEX Hypotheses | Cell-Type Specific TFEB Modulation The Mitochondrial-Lysosomal Metabolic Coupling Dys Radiation drives pericyte senescence through lysos (+4 more) |
| KG Connections | 3007 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
TFEB["TFEB
(Master Regulator)"]
subgraph Activators["TFEB Activators"]
TRIM27["TRIM27
(E3 Ligase)"]
CREB1["CREB1
(Transcription Factor)"]
trehalose["Trehalose
(Metabolite)"]
QGJZF["QGJZF"]
end
subgraph Regulators["Upstream Regulators"]
MTORC1["mTORC1
(Kinase Complex)"]
AMBRA1["AMBRA1
(Autophagy Regulator)"]
end
subgraph TargetGenes["Target Genes/Proteins"]
LC3["LC3
(Autophagy Marker)"]
RRAG["RRAG
(Lysosomal Positioning)"]
BECN1["BECN1
(Autophagy Initiator)"]
end
subgraph Pathways["Regulated Pathways"]
autophagy["Autophagy"]
endocytosis["Endocytosis"]
lysosomal_biogenesis["Lysosomal Biogenesis"]
autophagic_pathway["Autophagy-Lysosomal Pathway"]
end
subgraph Outcomes["Physiological Outcomes"]
neurodegen["Neurodegenerative Disease
Modulation"]
alzheimers["Alzheimer's Disease
Treatment"]
end
TRIM27 -->|"activates"| TFEB
CREB1 -->|"activates"| TFEB
trehalose -->|"activates"| TFEB
QGJZF -->|"activates"| TFEB
MTORC1 -->|"regulates"| TFEB
AMBRA1 -->|"inhibits"| TFEB
TFEB -->|"regulates"| LC3
TFEB -->|"regulates"| RRAG
TFEB -->|"activates"| BECN1
TFEB -->|"activates"| autophagy
TFEB -->|"promotes"| endocytosis
TFEB -->|"regulates"| lysosomal_biogenesis
TFEB -->|"activates"| autophagic_pathway
autophagy -->|"linked to"| neurodegen
autophagic_pathway -->|"related to"| alzheimers
TFEB -->|"modulates"| neurodegen
TFEB -->|"treats"| alzheimers
classDef mainProtein fill:#ff6b6b,stroke:#c92a2a,stroke-width:3px,color:#e0e0e0,font-weight:bold
classDef protein fill:#4ecdc4,stroke:#1a9b8e,stroke-width:2px,color:#e0e0e0
classDef pathway fill:#95e1d3,stroke:#38ada9,stroke-width:2px,color:#e0e0e0
classDef outcome fill:#ffd93d,stroke:#f39c12,stroke-width:2px,color:#e0e0e0
classDef regulator fill:#a8dadc,stroke:#457b9d,stroke-width:2px,color:#e0e0e0
class TFEB mainProtein
class TRIM27,CREB1,LC3,RRAG,BECN1,QGJZF,trehalose,MTORC1,AMBRA1 protein
class autophagy,endocytosis,lysosomal_biogenesis,autophagic_pathway pathway
class neurodegen,alzheimers outcome
class Activators,Regulators regulator| Target | Relation | Type | Str |
|---|---|---|---|
| Als | activates | disease | 1.00 |
| AUTOPHAGY | activates | gene | 1.00 |
| Als | regulates | disease | 1.00 |
| autophagy | activates | pathway | 1.00 |
| Autophagy | activates | pathway | 1.00 |
| GENES | activates | gene | 1.00 |
| lysosome biogenesis | promotes | process | 0.95 |
| Endocytosis | upregulates | process | 0.95 |
| Tumor | activates | disease | 0.95 |
| FAM134B | upregulates | gene | 0.95 |
| lysosomal pool regeneration | regulates | process | 0.95 |
| MAFLD | regulates | disease | 0.95 |
| syncytiotrophoblast formation | promotes | process | 0.95 |
| syncytiotrophoblast differentiation | regulates | process | 0.95 |
| lysosomal function | activates | process | 0.95 |
| mitochondrial function | activates | process | 0.95 |
| AUTOPHAGY | regulates | pathway | 0.94 |
| autophagy | regulates | process | 0.94 |
| diabetic encephalopathy | therapeutic_target | disease | 0.93 |
| intestinal permeability | modulates | phenotype | 0.92 |
| Autophagosome and Lysosome Biogenesis | upregulates | pathway | 0.92 |
| renal tumorigenesis | promotes | process | 0.92 |
| NLRP3 | promotes | protein | 0.92 |
| Lysosomal Activity | upregulates | process | 0.90 |
| PPARGC1A | activates | gene | 0.90 |
| Lysosomal Biogenesis | regulates | process | 0.90 |
| trophoblast differentiation | promotes | process | 0.90 |
| autophagy gene activation | mediates | process | 0.90 |
| breast cancer | therapeutic_target | disease | 0.90 |
| metabolic dysfunction-associated steatohepatitis | protects_against | disease | 0.90 |
| NFE2L2 | regulates | gene | 0.90 |
| SYNB | binds_to | gene | 0.90 |
| lysosomal homeostasis | regulates | process | 0.90 |
| lysosomal genes | upregulates | pathway | 0.90 |
| microglia activation | inhibits | process | 0.90 |
| Lysosome Biogenesis | associated_with | process | 0.90 |
| tauopathy | therapeutic_target | disease | 0.90 |
| Amyloid-Beta Clearance | activates | process | 0.90 |
| Lysosome Biogenesis | activates | process | 0.90 |
| 17β-Estradiol production | modulates | process | 0.90 |
| lysosomal biogenesis | regulates | process | 0.90 |
| LC3 | regulates | protein | 0.90 |
| placental hormone secretion | regulates | process | 0.90 |
| CYP19A1 | associated_with | gene | 0.90 |
| Autophagy-Lysosomal Pathway | mediates | pathway | 0.90 |
| NLRP3 inflammasome | inhibits | protein | 0.90 |
| autophagic flux | regulates | pathway | 0.90 |
| endocytosis | associated_with | pathway | 0.90 |
| SYNA | binds_to | gene | 0.90 |
| Lysosomal Transcripts | upregulates | biomarker | 0.90 |
| Source | Relation | Type | Str |
|---|---|---|---|
| TREHALOSE | activates | gene | 0.95 |
| TRPML1 | activates | protein | 0.95 |
| RAPAMYCIN | activates | drug | 0.95 |
| TMX2 | promotes_nuclear_import_of | protein | 0.95 |
| FLCN | inhibits | protein | 0.95 |
| trehalose | activates | drug | 0.95 |
| Treahalose | activates | compound | 0.95 |
| Sulforaphane | activates | compound | 0.95 |
| mTOR | phosphorylates | protein | 0.95 |
| mTORC1 | upstream_of | protein | 0.95 |
| Rag-GTPases | inhibits | protein | 0.95 |
| Urolithin A | activates | drug | 0.95 |
| cGAS-STING | activates | pathway | 0.95 |
| TRIP12 | ubiquitinates | protein | 0.93 |
| h-e3e8407c | targets | hypothesis | 0.90 |
| CREB1 | activates | protein | 0.90 |
| Trehalose | activates | compound | 0.90 |
| TRIM27 | activates | protein | 0.90 |
| Tnea Therapy | activates | drug | 0.90 |
| IRISIN | activates | protein | 0.90 |
| Qigui Jiangzhi Formula | upregulates | drug | 0.90 |
| ROCK1 | phosphorylates | gene | 0.90 |
| PPP3 | phosphorylates | gene | 0.90 |
| MTORC1 | inhibits | gene | 0.90 |
| h-e5a1c16b | targets_gene | hypothesis | 0.90 |
| tetrandrine | modulates | compound | 0.90 |
| TMX2 | modulates | protein | 0.90 |
| rapamycin | targets | drug | 0.90 |
| PRKAA | activates | gene | 0.90 |
| Mc3R Agonists | activates | drug | 0.90 |
| h-b9acf0c9 | targets | hypothesis | 0.90 |
| mTOR inhibition | activates | process | 0.90 |
| h-1775578a | targets | hypothesis | 0.90 |
| GABARAP | inhibits | protein | 0.88 |
| 1433 | binds_to | protein | 0.85 |
| nutrient insufficiency | modulates | process | 0.85 |
| Lysosomal-Mediated Activation | regulates | mechanism | 0.85 |
| mTORC1 | phosphorylates | protein | 0.85 |
| MTOR | associated_with | protein | 0.85 |
| TSC2 | regulates | gene | 0.85 |
| STAT3 | inhibits | entity | 0.85 |
| Acetylation | modulates | mechanism | 0.85 |
| ACSS2 | binds | protein | 0.85 |
| TAL1 | regulates | enzyme | 0.85 |
| ELTROMBOPAG | inhibits | drug | 0.85 |
| PPP2 | phosphorylates | protein | 0.85 |
| HESPERIDIN | activates | compound | 0.85 |
| MC3R | modulates | protein | 0.85 |
| TFEB phosphorylation | regulates | mechanism | 0.85 |
| Acetylation | regulates | process | 0.80 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
neurodegeneration | 2026-04-25 | 6 hypotheses Top: 0.583
proteomics | 2026-04-16 | 7 hypotheses Top: 0.533
neurodegeneration | 2026-04-13 | 2 hypotheses Top: 0.793
neurodegeneration | 2026-04-13 | 2 hypotheses Top: 0.584
neurodegeneration | 2026-04-11 | 0 hypotheses
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Trehalose-induced lysosomal membrane permeabilization and TFEB activat | exploratory | motoneuron degeneration | 0.900 | 0.00 | NSC34 neuroblastoma cells | proposed | N/A |
| Trehalose-induced lysosomal changes and TFEB activation | exploratory | motoneuron degeneration | 0.900 | 0.00 | NSC34 neuroblastoma x spinal c | proposed | N/A |
| Transcriptome sequencing of cardiac fibroblasts in TFEB overexpressing | exploratory | myocardial infarction | 0.900 | 0.00 | R26-LSL-TFEB+/+; Acta2-cre mic | proposed | N/A |
| TFEB silencing and misfolded protein degradation | exploratory | motoneuron degeneration | 0.880 | 0.00 | NSC34 neuroblastoma x spinal c | proposed | N/A |
| Protein expression analysis and cell migration assays in cardiac fibro | exploratory | cardiac fibrosis | 0.880 | 0.00 | primary cardiac fibroblasts fr | proposed | N/A |
| Functional validation of trehalose effects on misfolded protein cleara | exploratory | motoneuron degeneration diseas | 0.850 | 0.00 | cell models expressing misfold | proposed | N/A |
| ChIP-qPCR validation of TFEB binding to Thbs1 promoter | exploratory | cardiac fibrosis | 0.850 | 0.00 | mouse cardiac fibroblasts | proposed | N/A |
| Trehalose analog testing for autophagy induction | exploratory | motoneuron degeneration | 0.820 | 0.00 | NSC34 neuroblastoma x spinal c | proposed | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Autophagy and ALS: mechanistic insights and therapeutic implications. [PMID:34057020] | Chua JP, De Calbiac H, Kabashi E, Barmad | Autophagy | 2022 | 2 |
| Trehalose induces autophagy via lysosomal-mediated TFEB activation in models of [PMID:30335591] | Rusmini P, Cortese K, Crippa V, Cristofa | Autophagy | 2019 | 2 |
| Acetylation in the regulation of autophagy. [PMID:35435793] | Xu Y, Wan W | Autophagy | 2023 | 1 |
| Chemical and Molecular Strategies in Restoring Autophagic Flux in TDP-43 Protein [PMID:41900026] | Jamerlan A, Hulme J | Molecules (Basel, Switzerland) | 2026 | 0 |
| Enhanced lysosomal activity prevents infection with PrPSc and the seeding activi [PMID:41391758] | Mercer RCC, Le NTT, Mirza-Romero NA, Orb | The Journal of biological chem | 2026 | 0 |
| Mammalian lipophagy: process and function. [PMID:41681129] | Zhao R, Dai E, Kang R, Liu J, Klionsky D | Autophagy | 2026 | 0 |
| PSAT1 inhibits mTORC1 activation by preventing Rag heterodimer formation in lung [PMID:40702660] | Liu Y, Cheng Z, Zhang J, Zhang Y, Zhao T | Autophagy | 2026 | 0 |
| Electroacupuncture regulates neuronal ferroptosis and ferritinophagy through lys [PMID:41272418] | Tang B, Xu X, Zhao W, Zhou Q, Du G et al | J Cereb Blood Flow Metab | 2026 | 0 |
| Nanocarrier-enhanced simvastatin modulates AMPK-ULK1 pathway and oxidative stres [PMID:41314452] | Afify AM, El-Sayed EK, Ismail A, Nofal S | Eur J Pharmacol | 2026 | 0 |
| Macrophage PD-1 regulates energy expenditure and metabolic dysfunction under imm [PMID:41380676] | Wu MM, Yang YC, Hu ZQ, Chang JY, Xiao H | Cell Metab | 2026 | 0 |
| Maspardin/SPG21 controls lysosome motility and TFEB phosphorylation through RAB7 [PMID:41400694] | Jacqmin T, Gilis F, Albert M, Gaussin JF | J Cell Biol | 2026 | 0 |
| Endothelial Transcription Factor EB Protects Against Doxorubicin-Induced Endothe [PMID:41410033] | Du W, Ringer M, Desai D, Khandakar GI, T | Circulation | 2026 | 0 |
| Proteotoxic stress triggers TFEB- and TFE3-mediated autophagy and lysosomal biog [PMID:41450115] | Zhu Z, Yang J, Montefusco S, Xia S, Ou J | Autophagy | 2026 | 0 |
| β-Sitosterol ameliorates metabolic dysfunction-associated steatohepatitis by tar [PMID:41501416] | Wang Y, Sun Y, Wang CY, Cao M, Hao R et | Acta Pharmacol Sin | 2026 | 0 |
| Epigenetic H3K4me3 activation of miR-155-5p promotes intervertebral disc degener [PMID:41536620] | Wang X, Sun H, Xiao W, Zhang Y, Lu X et | Noncoding RNA Res | 2026 | 0 |
| AMPK promotes TFEB transcriptional activity through dephosphorylation at both MT [PMID:41661247] | Negoita F, Fraguas Bringas C, Hellberg K | Autophagy | 2026 | 0 |
| Microglia TFEB activation attenuates Alzheimer's disease pathology by enhancing [PMID:41673711] | Kim Y, Ha TY, Kondaurova O, Lee MS, Chan | J Neuroinflammation | 2026 | 0 |
| Neuronal PPP2R5C in plasma is a potential biomarker for early diagnosis of Alzhe [PMID:41720088] | Luo S, Liu H, Xiao T, Li Y, Liu X et al. | Cell Rep Med | 2026 | 0 |
| Prussian Blue Nanozyme Disrupts the Self-Reinforcing Loop of Tauopathy via Tripl [PMID:41797478] | Wu F, Huang J, Wang J, Wu R, Zhang H et | Adv Healthc Mater | 2026 | 0 |
| SLC38A9 Regulation Affects Hippocampal Neuronal Autophagy: A Potential Alzheimer [PMID:41811103] | Chen Y, Ji X, Zhao J, Bao Z, Huang Y | CNS Neurosci Ther | 2026 | 0 |
Multi-agent debates referencing this entity
completed · Rounds: 5 · Score: 0.50 · 2026-04-25
closed · Rounds: 4 · Score: 0.76 · 2026-04-22
closed · Rounds: 4 · Score: 0.61 · 2026-04-21
closed · Rounds: 4 · Score: 0.73 · 2026-04-21
closed · Rounds: 4 · Score: 0.60 · 2026-04-21
closed · Rounds: 4 · Score: 0.30 · 2026-04-21
closed · Rounds: 4 · Score: 0.50 · 2026-04-20
closed · Rounds: 4 · Score: 1.00 · 2026-04-20
closed · Rounds: 4 · Score: 0.50 · 2026-04-18
closed · Rounds: 4 · Score: 0.78 · 2026-04-13
Hypotheses and analyses mentioning TFEB in their description or question text
Score: 0.677 · neurodegeneration · 2026-04-04
## Mechanistic Overview Cell-Type Specific TFEB Modulation starts from the claim that modulating TFEB within the disease
Score: 0.652 · neurodegeneration · 2026-04-02
## Mechanistic Overview The Mitochondrial-Lysosomal Metabolic Coupling Dysfunction starts from the claim that modulating
Score: 0.652 · neurodegeneration · 2026-04-25
Autophagosomes still form after irradiation, but damaged lysosomes cannot clear cargo, sustaining ROS and SASP output.
Score: 0.650 · neurodegeneration · 2026-04-21
## Mechanistic Overview mTORC1 displacement from lysosomal surface enables calcineurin access to TFEB starts from the cl
Score: 0.622 · neurodegeneration · 2026-04-02
## Mechanistic Overview TFEB-PGC1α Mitochondrial-Lysosomal Decoupling starts from the claim that modulating TFEB within
Score: 0.619 · neurodegeneration · 2026-04-04
## Mechanistic Overview Lysosomal pH Restoration Upstream of TFEB starts from the claim that modulating ATP6V1A within t
Score: 0.609 · neurodegeneration · 2026-04-04
## Mechanistic Overview Temporal TFEB Modulation Therapy starts from the claim that modulating TFEB within the disease c
Score: 0.602 · neurodegeneration · 2026-04-04
## Mechanistic Overview Selective TFEB Cofactor Enhancement starts from the claim that modulating TFE3 within the diseas
Score: 0.584 · neurodegeneration · 2026-04-13
## Mechanistic Overview PIKFYVE Inhibition Activates Aggregate Exocytosis via PI(3,5)P2→TRPML1→Calcineurin→TFEB Cascade
Score: 0.578 · neurodegeneration · 2026-04-26
Motor neurons exhibit constitutive mTORC1 activation that phosphorylates TFEB/TFE3 transcription factors, sequestering t
Score: 0.565 · neuroscience · 2026-04-22
## Mechanistic Overview Synergistic enhancement of autophagy and lysosomal biogenesis by combined mTOR inhibition and TF
Score: 0.560 · neurodegeneration · 2026-04-22
## Mechanistic Overview TFEB Activation Clears Tau-Loaded Endolysosomal Compartments, Preventing Release for Transcellul
Score: 0.560 · neurodegeneration · 2026-04-25
HBOT increases mTORC1 inhibition, promoting TFEB nuclear translocation and enhancing autophagy flux to clear pathologica
Score: 0.549 · neurodegeneration · 2026-04-04
## Mechanistic Overview YWHAG-Mediated TFEB Subcellular Targeting starts from the claim that modulating YWHAG within the
Score: 0.533 · proteomics · 2026-04-25
TFEB Activation to Restore Lysosomal Biogenesis in Aged Synapses